What Is “Next Generation Protein Sequencing”?

Next Generation Protein Sequencing (NGPS) refers to a suite of emerging high-throughput technologies designed to determine the amino acid sequences of proteins at scale, analogous in ambition to Next Generation Sequencing (NGS) in genomics. While NGS revolutionized DNA and RNA analysis by enabling massively parallel sequencing, NGPS seeks to achieve a comparable transformation in proteomics—allowing direct, large-scale, and potentially single-molecule protein sequencing rather than indirect inference through mass spectrometry.

To understand NGPS clearly, it is useful to first examine how it relates to and differs from established NGS methods.


Next Generation Sequencing (NGS)

Next Generation Sequencing refers to high-throughput DNA sequencing technologies that emerged in the mid-2000s. Platforms such as those developed by Illumina and Ion Torrent allow millions to billions of DNA fragments to be sequenced in parallel.

Core characteristics of NGS:

  • Massively parallel sequencing reactions

  • Sequencing-by-synthesis or semiconductor-based detection

  • Digital base calling (A, T, G, C)

  • High throughput and decreasing per-base cost

  • Applicability to genomics, transcriptomics, metagenomics, and epigenomics

NGS reads nucleic acid sequences composed of four canonical bases. Importantly, DNA sequencing is facilitated by predictable base pairing, enzymatic amplification (PCR), and relatively uniform chemical properties of nucleotides.

Proteins, however, are far more complex analytical targets.


Next Generation Protein Sequencing (NGPS)

Next Generation Protein Sequencing is an umbrella term describing technologies under development that aim to directly sequence proteins at high throughput and single-molecule resolution. Unlike traditional proteomics—primarily reliant on mass spectrometry—NGPS attempts to determine amino acid order directly, analogous to DNA sequencing.

While NGPS is still in development and not yet as mature as NGS, it represents a transformative goal in molecular biology.


Why Protein Sequencing Is Harder Than DNA Sequencing

There are fundamental biochemical and analytical challenges that distinguish protein sequencing from nucleic acid sequencing:

1. Alphabet Complexity

  • DNA: 4 nucleotides

  • Proteins: 20 standard amino acids

This fivefold increase in chemical diversity significantly complicates detection.

2. No Amplification Equivalent

DNA can be amplified via PCR. Proteins cannot be enzymatically amplified. Each molecule must be detected directly.

3. Structural Complexity

Proteins fold into secondary, tertiary, and quaternary structures. Sequencing technologies must often unfold or linearize them.

4. Post-Translational Modifications (PTMs)

Proteins undergo phosphorylation, glycosylation, methylation, acetylation, and more. These modifications alter function but are not encoded in DNA.

NGPS must account not only for amino acid sequence but potentially for PTMs—something NGS does not encounter.


Traditional Protein Sequencing vs NGPS

Before NGPS concepts emerged, protein sequencing relied primarily on:

1. Edman degradation

A stepwise chemical method that removes one amino acid at a time from the N-terminus.
Limitations:

  • Low throughput

  • Requires relatively large amounts of purified protein

  • Poor performance on modified proteins

2. Mass spectrometry (MS-based proteomics)

Modern proteomics typically uses MS to identify peptides after enzymatic digestion.

Workflow:

  • Proteins digested into peptides

  • Peptides ionized

  • Mass-to-charge ratios measured

  • Sequences inferred computationally

While highly powerful, MS-based proteomics is indirect and depends heavily on database matching. It struggles with:

  • Low-abundance proteins

  • Single-cell resolution

  • Complete de novo sequencing

NGPS aims to overcome these limitations by enabling direct sequencing.


Major Technological Approaches in NGPS

Several strategies are being explored:


1. Nanopore-Based Protein Sequencing

Inspired by nanopore DNA sequencing (e.g., Oxford Nanopore Technologies), this method involves passing a protein through a nanoscale pore while measuring electrical current disruptions.

Principle:

  • Individual amino acids produce characteristic ionic current changes.

  • Sequential reading yields the amino acid sequence.

Challenges:

  • Amino acid signal overlap

  • Control of protein translocation speed

  • Signal-to-noise discrimination

If solved, nanopore protein sequencing could allow portable, real-time proteomics analogous to handheld DNA sequencers.


2. Fluorescence-Based Single-Molecule Sequencing

Some NGPS platforms use fluorescent labeling of specific amino acids.

Workflow concept:

  • Immobilize protein molecules on a surface

  • Sequentially remove amino acids

  • Detect fluorescent signals for labeled residues

  • Reconstruct sequence computationally

This approach mirrors sequencing-by-synthesis chemistry used in NGS but applied to amino acids.


3. Tunneling Current Detection

In this approach, amino acids pass between nanoelectrodes, generating unique electron tunneling signatures.

Advantages:

  • Label-free detection

  • Potential single-molecule resolution

However, signal reproducibility and discrimination remain technical challenges.


4. Protease-Based Stepwise Cleavage

Some NGPS concepts involve:

  • Sequential protease cleavage

  • Real-time detection of released amino acids

  • Digital counting similar to DNA base incorporation

This hybrid biochemical–electronic method aims to mimic the controlled sequential chemistry of NGS.


Is NGPS Similar to NGS?

Conceptually: Yes.
Technologically: Partially.

Similarities

  1. High-throughput goal
    Both aim to analyze millions of molecules in parallel.

  2. Single-molecule resolution
    Many NGPS approaches aim for single-protein sequencing, analogous to single-molecule DNA sequencing.

  3. Digital signal detection
    Both convert molecular events into measurable electronic or optical signals.

  4. Platform miniaturization
    Chip-based, surface-bound sequencing architectures are common to both.


Differences

Feature NGS NGPS
Target molecule DNA/RNA Protein
Alphabet size 4 bases 20 amino acids
Amplification PCR possible No amplification
Chemical uniformity High Highly diverse side chains
PTMs Indirect detection Directly observable (potentially)
Technological maturity Fully commercial Emerging

In short, NGPS is philosophically modeled after NGS but faces substantially greater chemical and analytical complexity.


Why NGPS Matters

If fully realized, NGPS would transform proteomics in ways comparable to how NGS transformed genomics.

1. Single-Cell Proteomics

Direct sequencing from individual cells without bulk averaging.

2. Rare Protein Detection

Enhanced sensitivity for low-abundance biomarkers.

3. Precision Medicine

Protein-level diagnostics could outperform DNA-based predictions, since proteins execute biological function.

4. Direct PTM Mapping

Real-time identification of phosphorylation, glycosylation, and other modifications.

5. De Novo Protein Sequencing

Identification of unknown proteins without genomic reference databases.


Current Status of NGPS

Unlike NGS, which is widely deployed in research and clinical laboratories, NGPS remains largely in advanced development and early commercialization stages. Several biotechnology startups and academic labs are working toward:

  • Higher signal discrimination

  • Controlled enzymatic stepping

  • Improved surface chemistry

  • Machine learning-based amino acid identification

Machine learning is particularly important because amino acid signals may overlap; pattern recognition algorithms can improve accuracy.


Relationship to the Central Dogma

NGS operates primarily at the genomic and transcriptomic level. NGPS operates at the proteomic level—the final functional output of gene expression.

DNA → RNA → Protein

While genomics reveals potential biological outcomes, proteomics reveals what is actually happening in a cell at a functional level. Therefore, NGPS could provide more direct insights into disease mechanisms, immune responses, cancer heterogeneity, and therapeutic targets.


Future Outlook

If NGPS achieves scalability comparable to NGS, we may see:

  • Portable protein sequencers

  • Clinical proteomic diagnostics

  • Real-time monitoring of therapeutic protein drugs

  • Personalized proteome mapping

However, major engineering hurdles remain before NGPS becomes routine.


Next Generation Protein Sequencing is an emerging class of technologies aiming to perform high-throughput, single-molecule protein sequencing, analogous in ambition to Next Generation Sequencing for DNA. While NGS reads nucleic acids using well-established biochemical principles and amplification methods, NGPS must overcome greater chemical diversity, structural complexity, and lack of amplification.

Thus, NGPS is conceptually similar to NGS in its goals—massively parallel, digital, high-resolution sequencing—but technologically far more complex. If realized at scale, NGPS would represent a paradigm shift in proteomics comparable to the genomic revolution initiated by NGS.

Visited 2 times, 1 visit(s) today

Be the first to comment

Leave a Reply

Your email address will not be published.


*


This site uses Akismet to reduce spam. Learn how your comment data is processed.